LU87980A1 - Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique,et sa preparation - Google Patents

Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique,et sa preparation Download PDF

Info

Publication number
LU87980A1
LU87980A1 LU87980A LU87980A LU87980A1 LU 87980 A1 LU87980 A1 LU 87980A1 LU 87980 A LU87980 A LU 87980A LU 87980 A LU87980 A LU 87980A LU 87980 A1 LU87980 A1 LU 87980A1
Authority
LU
Luxembourg
Prior art keywords
hydrochloric acid
hydrochloride
active component
donor
composition according
Prior art date
Application number
LU87980A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU87980A1 publication Critical patent/LU87980A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU87980A 1990-07-25 1991-07-23 Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique,et sa preparation LU87980A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55723490A 1990-07-25 1990-07-25

Publications (1)

Publication Number Publication Date
LU87980A1 true LU87980A1 (fr) 1993-02-15

Family

ID=24224569

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87980A LU87980A1 (fr) 1990-07-25 1991-07-23 Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique,et sa preparation

Country Status (30)

Country Link
EP (1) EP0468929B1 (pl)
JP (1) JP2502849B2 (pl)
KR (1) KR100227156B1 (pl)
AT (1) AT400519B (pl)
AU (1) AU639354B2 (pl)
CA (1) CA2047802C (pl)
CH (1) CH683150A5 (pl)
CZ (1) CZ280184B6 (pl)
DE (1) DE4124409B4 (pl)
DK (1) DK0468929T3 (pl)
ES (1) ES2061218T3 (pl)
FI (1) FI98127C (pl)
GB (1) GB2246296B (pl)
HU (1) HU222489B1 (pl)
IE (1) IE66184B1 (pl)
IL (1) IL98934A (pl)
IT (1) IT1290797B1 (pl)
LU (1) LU87980A1 (pl)
MX (1) MX9100357A (pl)
MY (1) MY107183A (pl)
NO (1) NO912872D0 (pl)
NZ (1) NZ239078A (pl)
PL (1) PL167712B1 (pl)
PT (1) PT98417B (pl)
RU (1) RU2075310C1 (pl)
SA (1) SA92130106B1 (pl)
SK (1) SK278563B6 (pl)
TW (1) TW212757B (pl)
UA (1) UA26064A1 (pl)
ZA (1) ZA915861B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789597A (en) * 1994-07-13 1998-08-04 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Process for the preparation of compounds having ACE inhibitory action and intermediates in said process
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
HU222497B1 (hu) * 1996-12-18 2003-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására
ID27398A (id) 1998-06-05 2001-04-05 Warner Lambert Co Stabilisasi komposisi yang mengandung inhibitor ace dengan menggunakan magnesium oksida
KR100483080B1 (ko) * 2001-09-21 2005-04-14 한인규 염산·베타인(betaine·HCl), 판크레아틴, 제2인산 칼슘, 크롬 피콜리네이트, 락토바실러스속·비피도박테리아속·스트렙토코커스속·프럭토 올리고당, 비타민, 미네랄을 유효성분으로 구성된 것을 특징으로 하는 증체개선용 영양강화 사료첨가제
US6462022B1 (en) † 2001-09-24 2002-10-08 Astrazeneca Ab Lisinopril compositions having large-particle DCPD
US20050118259A1 (en) * 2002-01-15 2005-06-02 Renir Eyjolfsson Formulations of quinapril and related ace nhibitors
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
KR20200013714A (ko) 2017-05-31 2020-02-07 베링거 인겔하임 인터내셔날 게엠베하 (e)-4-(2-(아미노메틸)-3-플루오로알릴옥시)-n-3급-부틸벤즈아미드를 포함하는 약제학적 조성물 및 약제학적 투여 형태, 이들의 제조 방법, 이의 치료 방법 및 용도

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895027A (en) * 1959-08-03 1962-04-26 Bristol Myers Co Therapeutic tetracycline compositions
GB1437788A (en) * 1973-01-31 1976-06-03 Gist Brocades Nv Therapeutic compositions
HU173823B (hu) * 1975-07-25 1979-08-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija stabil'nogo lechebnogo preparata dlja oral'noj dozirovki, kotoryj soderzhit proizvodnyj gomopirimidazola
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
US4575539A (en) * 1985-06-03 1986-03-11 E. R. Squibb & Sons, Inc. Drug delivery systems including novel interpenetrating polymer networks and method
US4900559A (en) * 1985-12-12 1990-02-13 Briston-Myers Company Stabilized enteric coated aspirin granules and process of preparation
DE3627613A1 (de) * 1986-08-14 1988-02-18 Merck Patent Gmbh Pharmazeutische zubereitung
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
AU608891B2 (en) * 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US4912096A (en) * 1989-06-26 1990-03-27 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing an ace inhibitor

Also Published As

Publication number Publication date
TW212757B (pl) 1993-09-11
AU8128691A (en) 1992-01-30
ZA915861B (en) 1993-03-31
IT1290797B1 (it) 1998-12-11
IL98934A0 (en) 1992-07-15
PL167712B1 (en) 1995-10-31
ITRM910554A0 (it) 1991-07-23
DK0468929T3 (da) 1994-12-27
GB2246296A (en) 1992-01-29
GB2246296B (en) 1994-04-06
GB9115893D0 (en) 1991-09-04
IE66184B1 (en) 1995-12-13
KR100227156B1 (ko) 1999-10-15
ITRM910554A1 (it) 1993-01-23
SA92130106B1 (ar) 2005-10-16
ATA147691A (de) 1995-06-15
IL98934A (en) 1996-07-23
EP0468929A3 (en) 1992-02-19
HUT59819A (en) 1992-07-28
EP0468929B1 (en) 1994-09-28
HU9102385D0 (en) 1991-12-30
IE912608A1 (en) 1992-01-29
PT98417B (pt) 1999-01-29
CZ280184B6 (cs) 1995-11-15
DE4124409B4 (de) 2004-11-18
PT98417A (pt) 1992-06-30
MY107183A (en) 1995-09-30
FI913554A (fi) 1992-01-26
FI913554A0 (fi) 1991-07-24
EP0468929A2 (en) 1992-01-29
NZ239078A (en) 1993-10-26
RU2075310C1 (ru) 1997-03-20
PL291219A1 (en) 1992-08-24
CS230991A3 (en) 1992-04-15
AU639354B2 (en) 1993-07-22
NO912872D0 (no) 1991-07-23
SK278563B6 (en) 1997-10-08
AT400519B (de) 1996-01-25
DE4124409A1 (de) 1992-01-30
HU222489B1 (hu) 2003-07-28
JPH04253923A (ja) 1992-09-09
CA2047802A1 (en) 1992-01-26
UA26064A1 (uk) 1999-04-30
CH683150A5 (de) 1994-01-31
FI98127B (fi) 1997-01-15
CA2047802C (en) 2003-05-06
JP2502849B2 (ja) 1996-05-29
MX9100357A (es) 1992-02-28
KR920002146A (ko) 1992-02-28
ES2061218T3 (es) 1994-12-01
FI98127C (fi) 1997-04-25

Similar Documents

Publication Publication Date Title
JP3254219B2 (ja) 安定な経口用のｃｉ−９８１製剤およびその製法
CA2271865C (en) Tablet composition
EP1354873B1 (fr) Sel de périndopril et les compositions pharmaceutiques qui le contiennent
AU614710B2 (en) Stabilized drug compositions
LU87980A1 (fr) Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique,et sa preparation
CA1329773C (fr) Compositions pharmaceutiques utiles pour le traitement de l'uremie
US6300361B1 (en) Stabilized pharmaceutical compositions comprising acid donors
HU211478A9 (en) Pharmaceutical composition and process for the preparation thereof
WO2018211479A1 (en) Stabilized compositions of angiotensin ii inhibitors and neutral endopeptidase inhibitors and process for preparation thereof
FR2676363A1 (fr) Antidote prophylactique contre les poisons organophosphoriques.
KR19990076302A (ko) 프라바스타틴나트륨이 함유된 약제 조성물
EP0983065A1 (fr) Composition pharmaceutique a residence gastrique
FR2673375A1 (fr) Utilisation de la cucurbitine pour la preparation d'une composition cosmetique ou pharmaceutique, notamment dermatologique, anti-allergique, et procede en comportant application.
FR2665834A1 (fr) Composition pharmaceutique stabilisee par un donneur d'acide chlorhydrique, et sa preparation.
EA001673B1 (ru) Применение ингибиторов катехол-о-метилтрансферазы (комт) для производства лекарственного средства для профилактики сосудистых дисфункций при диабете
CN1762354A (zh) 一种含有钙阻滞剂的稳定药物组合物
FR2616068A1 (fr) Procede de stabilisation des principes actifs de produits vegetaux et les compositions pharmaceutiques renfermant lesdits principes actifs stabilises
CA2396180C (fr) Solution aqueuse stable de deoxyfructosazine
CH622023A5 (en) Process for the preparation of a water-soluble compound based on a substituted phenylaminoalcohol
MX2008007383A (en) Complex formulation comprising amlodipine camsylate and simvastatin and method for preparation thereof
FR2771006A1 (fr) Association de principes actifs pour le traitement de la demence senile du type alzheimer